MEDICLIN AG (GB:0NDG)

LSE:0NDG

0NDG

MEDICLIN

RESEARCH TOOLSreports

Want to see GB:0NDG full AI Analyst Report?

MEDICLIN (0NDG) Price & Analysis

0 Followers

0NDG Stock Chart & Stats

€3.60

€0.00(0.00%)

At close: Jan 08 4:00 PM EST

€3.60

€0.00(0.00%)

Day’s Range― - ―

52-Week Range€2.86 - €4.04

Previous CloseN/A

Volume0.00

Average Volume (3M)64.00

Market Cap

€171.00M

Enterprise Value€462.27M

Total Cash (Recent Filing)€152.40M

Total Debt (Recent Filing)€369.54M

Price to Earnings (P/E)12.1

Beta-0.09

Next Earnings

Jul 30, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.60

Shares Outstanding47,500,000

10 Day Avg. Volume29

30 Day Avg. Volume64

Financial Highlights & Ratios

PEG Ratio1.79

Price to Book (P/B)0.71

Price to Sales (P/S)0.22

P/FCF Ratio3.42

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)0.78

Revenue Forecast (FY)€805.74M

Bulls Say, Bears Say

Bulls Say

Revenue Growth And Improving Operating PerformanceSustained TTM revenue growth (up ~26%) with positive EBIT and net margins indicates expanding utilization and service uptake across clinics. This durable top-line improvement supports scale economics, covers fixed costs, and underpins sustainable operating cash flow and reinvestment capacity.

Consistent Cash GenerationHealthy operating cash flow (~€94m TTM) and positive free cash flow (~€49m TTM) give the company durable internal funding to service debt, fund capex and modest dividends. Reliable cash generation improves financial resilience and enables gradual deleveraging even if growth slows.

Diversified Clinical Services And Business ModelA business model spanning inpatient, outpatient and rehabilitation revenue streams diversifies demand and payer exposure. That multi‑site, multi‑service footprint produces recurring revenue from essential healthcare services and helps smooth utilization and revenue through cycles.

Bears Say

Elevated LeverageA debt-to-equity ratio near 1.46x leaves the capital structure relatively heavy and reduces financial flexibility. High leverage increases interest and refinancing risk, constrains capacity for M&A or capex, and makes the firm more vulnerable to earnings volatility or adverse funding conditions.

Thin And Volatile MarginsModest EBIT and net margins limit the buffer against cost inflation and reduce retained earnings for reinvestment. Historical margin volatility, including a prior loss year, undermines predictability of profits and cash flow, complicating medium-term planning and deleveraging efforts.

Weak Free Cash Flow Conversion And Negative FCF GrowthNegative free cash flow growth and FCF roughly 50% of reported net income indicate constrained cash conversion. This slows the pace of debt reduction, limits discretionary investment, and may force reliance on external funding if margins or volumes weaken, pressuring long-term stability.

0NDG FAQ

What was MEDICLIN AG’s price range in the past 12 months?

MEDICLIN AG lowest share price was €2.86 and its highest was €4.04 in the past 12 months.

What is MEDICLIN AG’s market cap?

MEDICLIN AG’s market cap is €171.00M.

When is MEDICLIN AG’s upcoming earnings report date?

MEDICLIN AG’s upcoming earnings report date is Jul 30, 2026 which is in 67 days.

How were MEDICLIN AG’s earnings last quarter?

MEDICLIN AG released its earnings results on May 04, 2026. The company reported €0.074 earnings per share for the quarter, beating the consensus estimate of N/A by €0.074.

Is MEDICLIN AG overvalued?

According to Wall Street analysts MEDICLIN AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does MEDICLIN AG pay dividends?

MEDICLIN AG does not currently pay dividends.

What is MEDICLIN AG’s EPS estimate?

MEDICLIN AG’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does MEDICLIN AG have?

MEDICLIN AG has 47,500,000 shares outstanding.

What happened to MEDICLIN AG’s price movement after its last earnings report?

MEDICLIN AG reported an EPS of €0.074 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.299%.

Which hedge fund is a major shareholder of MEDICLIN AG?

Currently, no hedge funds are holding shares in GB:0NDG

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

MEDICLIN Stock Smart Score

Neutral

Fundamentals

Return on Equity

10.71%

Trailing 12-Months

Asset Growth

-6.83%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

MEDICLIN AG

MEDICLIN Aktiengesellschaft operates hospitals in Germany. The company operates through Post-Acute, Acute, and Other Activities segments. It offers medical services in the areas of neurology, psychosomatics, orthopaedics, internal medicine, cardiology, oncology, geriatrics, psychiatry, surgery, nursing care, and others. The company also provides services in the areas of ENT and acute outpatient services. As of December 31, 2021, it owned 34 clinics, 7 nursing care facilities, and 11 medical care centres with a total capacity of 7,831 beds and 482 nursing places in 11 German federal states. The company is headquartered in Offenburg, Germany.